Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age

Keyphrases

• Childhood Cancer 100%
• Dutch 100%
• Radiation Dose 100%
• Cranial Radiotherapy 100%
• Cranial Volume 100%
• Cancer Oncology 100%
• Benign Meningioma 100%
• Hazard Ratio 60%
• Meningioma 60%
• Childhood Cancer Survivors 30%
• Radiotherapy Dose 30%
• Hazard Risk 30%
• Exposure Age 30%
• Survivors 20%
• Carboplatin 20%
• Excess Relative Risk 20%
• Pediatric 10%
• Treatment Protocol 10%
• Cumulative Incidence 10%
• Multivariable Cox Regression 10%
• Cancer Diagnosis 10%
• Risk Factors 10%
• Primary Cancer 10%
• Chemotherapy 10%
• Cisplatin 10%
• Methotrexate 10%
• Dose Effect 10%
• PALGA 10%
• High Dose 10%
• Dose-response 10%
• Population-based 10%
• Joint Effect 10%
• Adjusted Dose 10%
• Risk Modeling 10%
• Radiation Exposure 10%
• Adjusted Model 10%
• Partial Volume 10%
• Radiotherapy Volumes 10%
• Chemotherapy Agents 10%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Childhood Cancer 100%
• Oncology 100%
• Radiation Therapy 100%
• Meningioma 100%
• Hazard Ratio 60%
• Carboplatin 20%
• Dose Response 20%
• Pediatrics 10%
• Cancer Diagnosis 10%
• Proportional Hazards Model 10%
• Primary Tumor 10%
• Cumulative Incidence 10%
• Awareness 10%
• Cisplatin 10%
• Methotrexate 10%
• Drug Megadose 10%
• Chemotherapy Agent 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Childhood Cancer 100%
• Meningioma 100%
• Carboplatin 22%
• Primary Tumor 11%
• Chemotherapy 11%
• Cisplatin 11%
• Methotrexate 11%
• Chemotherapy Agent 11%